Market Overview - The Shanghai Composite Index experienced a rare 13 consecutive days of gains, breaking the previous high from November 14, 2025, and reaching a new high since July 2015, closing up by 1.50% [1] - The market saw over 4,100 stocks in the green, with significant contributions from financial sectors such as brokerage, insurance, and internet finance [1] Seasonal Trends - According to Zheshang Securities, the first quarter typically sees a "spring rally," where small and mid-cap growth indices perform best, setting the stage for February's market performance [1] Key Sectors Financial Sector - Major financial stocks like Dazhihui and Hualin Securities hit the daily limit, while China Ping An reached a new five-year high [1] Brain-Computer Interface - The brain-computer interface sector saw a surge, with nearly 20 stocks hitting the daily limit, driven by breakthroughs in clinical trials for a new fully implanted device [3] - The industry is expected to enter a critical phase of large-scale application, supported by policy backing and ongoing technological advancements [3] Non-Ferrous Metals - The non-ferrous metals sector strengthened, with companies like Luoyang Molybdenum and Zijin Mining reaching historical highs, influenced by rising global metal prices [4] - The London Metal Exchange reported significant price increases for tin and copper, indicating strong demand and supply dynamics [4] Solid-State Batteries - The solid-state battery sector experienced a rally, with several stocks hitting the daily limit, following the announcement of a commercially viable solid-state battery by Donut Lab [5] - The sector is expected to progress towards industrialization, supported by policy focus and active participation from industry players [5] Semiconductor Sector - The semiconductor sector remained active, with storage chips and semiconductor equipment leading the gains, as companies like Beifang Huachuang reached historical highs [6] - Price increases for DRAM chips were reported, with significant hikes expected in Q1 2026 [7] Institutional Insights - Guotai Junan Securities highlighted the internal trend of a "transformation bull market" in China, driven by economic shifts and capital market reforms [8] - Debon Securities expressed optimism for a slow bull market following the New Year, with expectations for continued upward movement in the A-share market [8] - Dongfang Securities noted that the market's upward trend is supported by strong investor confidence and the commercialization of new industries like brain-computer interfaces and AI [9]

Market Performance - The three major stock indices opened high and continued to rise, with the Shanghai Composite Index reaching a ten-year high, closing up 1.5% at 4083.67 points, marking a 13-day consecutive increase [1] - The Shenzhen Component Index rose 1.4% to 14022.55 points, while the ChiNext Index increased by 0.75% to 3319.29 points [1] - The total trading volume in the Shanghai and Shenzhen markets was 28065.75 billion yuan, an increase of 260.2 billion yuan compared to the previous trading day [1] - Over 4100 stocks in the market rose, with 143 stocks hitting the daily limit up, continuing a trend of over a hundred stocks hitting the limit up for two consecutive days [1] Sector Performance - The brain-computer interface concept continued to rise, with stocks like Sanbo Brain Science and Innovation Medical hitting the daily limit up [1] - The financial sector saw a significant increase, led by internet finance and brokerage stocks, with Dazhihui hitting the daily limit up [1] - The commercial aerospace concept surged, with China Satellite Communications achieving four limit ups in six days, and Goldwind Technology hitting three limit ups in seven days [1] - The intelligent driving sector also saw gains, with Wanji Technology hitting the daily limit up and several other related stocks following suit [1] - The retail sector experienced a boost, with Shanghai Jiubai hitting the daily limit up, alongside other retail stocks [1] Institutional Insights - Huaxi Securities predicts that 2026 will be a "big year" with multiple positive factors, indicating a solid foundation for a bull market [2] - Huatai Securities expects the spring market to strengthen further, recommending investment in growth sectors like electric power equipment and new energy [3] - CITIC Construction points out that the cross-year market may show characteristics of "growth leading, liquor accumulating," with a focus on sectors like snacks and dairy [4] - Tianfeng Securities highlights the growth potential in high-end consumption sectors such as cosmetics, gold and jewelry, and duty-free shopping [5]

Market Performance - The A-share market indices continued to rise, with the Shanghai Composite Index achieving a 13-day consecutive increase, reaching a 10-year high [1] - As of the market close, the Shanghai Composite Index rose by 1.5% to 4083 points, the Shenzhen Component Index increased by 1.4%, and the ChiNext Index rose by 0.75% [1] - The total market turnover was 2.83 trillion yuan, an increase of 265 billion yuan compared to the previous trading day, with over 4100 stocks rising [1] Sector Performance - The brain-computer interface sector saw significant gains, with stocks like Sanbo Brain Science, Weisi Medical, and Chengyitong hitting the daily limit [1] - Titanium dioxide companies collectively announced price increases, leading to a surge in the titanium dioxide sector, with Anning Co. and Vantone Co. hitting the daily limit [1] - Insurance stocks remained active, with Xinhua Insurance rising over 6% [1] - The aircraft carrier concept stocks also performed well, with companies like Beifang Navigation and Haige Communication hitting the daily limit [1] - Brokerage stocks rose, with Huashan Securities and Hualin Securities hitting the daily limit [1] - Other sectors with notable gains included under-screen photography, phosphorus chemicals, and small metals [1] Declining Sectors - The CPO concept experienced a downward trend, with Huilv Ecology falling over 7% [1] - The beauty and personal care sector declined, with Jiaheng Jiahua dropping nearly 9% [1] - Other sectors with significant declines included F5G concept and noise control [1] Recent Trends - The top sectors by net capital inflow over the past five days included petrochemicals, precious metals, and brokerages, with respective increases of 4.93%, 4.65%, and 4.15% [2] - Other sectors showing positive trends included power generation equipment and aerospace military industry, with increases of 3.88% and 3.78% respectively [2]

当前，脑机接口技术正推开规模化应用的大门。 跨年前夜，当"钢铁侠"马斯克在社交媒体上宣布2026年"神经连接"（Neuralink）将"大规模生产"脑机接 口设备，并转向"更加精简和几乎完全自动化的外科手术流程"时，世界的目光再次聚焦这场将重塑人机 关系的科技狂想。 事实上，在这场全球科技竞赛中，中国不再是追随者——从十年前默默耕耘，到如今在非侵入式赛道引 领风潮，以杭州"六小龙"之一的强脑科技（BrainCo）为代表的中国力量，已站上国际舞台中央。其创 始人兼CEO韩璧丞，这位哈佛博士未毕业就创业的"疯狂科学家"，正带领强脑科技向世界展示一条迥异 于Neuralink的东方路径：不追求以手术刀撬开颅骨的"连接"，而致力于用算法与传感解开大脑信号 的"密码"。 这背后，究竟藏着怎样的故事？ 高中毕业后，这位东北少年踏上了一条不寻常的国际化科研之路。 在韩国科学技术院（KAIST），一次偶然的学术探寻让韩璧丞了解到美国匹兹堡大学一项开创性实验： 一只猴子可以通过脑机接口控制机械臂给自己喂食可口的香蕉。"如果人类能直接用意念操控机器将带 来怎样的革命？" 为了离这个问题的答案更近一步，韩璧丞于2011年加入位于美 ...

Core Insights - The brain-computer interface (BCI) industry is in its early commercialization stage, with a focus on thematic investment opportunities and the progress of invasive clinical trials [1] - The Chinese BCI market is projected to reach approximately 1.73 billion yuan in 2023, accounting for 12.5% of the global market [2] Group 1: Industry Trends - BCI technology is experiencing a period of accelerated transformation, with various technical paths available, including invasive, semi-invasive, and non-invasive methods, each having distinct advantages in signal quality, safety, and operational difficulty [1] - The development trend in BCI is towards multimodal applications, with existing paradigms categorized into interactive control and state detection types [1] Group 2: Policy Support - The Chinese government has outlined clear support for the BCI industry through planning, payment, and standardization, with a strategic goal set for 2027 and 2030 to foster industry clusters and leading enterprises [2] - In March 2025, the National Healthcare Security Administration established an independent billing item for BCI, providing institutional support for clinical applications [2] - Standards for BCI terminology and data formats have been introduced, reducing costs and risks in technical development and clinical applications [2] Group 3: Technological Advancements and Applications - Core technological barriers in the BCI industry are concentrated in the upstream segment, including hardware (electrodes, chips), surgical procedures, and EEG signal processing [3] - The primary functions of BCI technology encompass monitoring, replacement, recovery enhancement, and supplementation, with a wide range of applications, particularly in the medical field [3] - In 2023, medical applications accounted for 56% of the BCI market in China, focusing on diagnosing consciousness and cognitive disorders, mental illnesses, motor disabilities, and sensory deficits [3]

Group 1 - The core focus of the news is the explosive growth of the brain-computer interface (BCI) sector in the A-share market, with significant stock price increases observed on the first trading day of 2026, particularly for companies involved in BCI technology [1][5] - Notable stock performances include BeiYikang with a 30% increase, and other companies like Sanbo Brain Science, Xiangyu Medical, and Meihai Medical all achieving around 20% gains [1][5] - The surge in the BCI sector is attributed to three major developments: Neuralink's announcement of large-scale production of BCI devices, the implementation of new industry standards in China, and successful clinical trials demonstrating the technology's effectiveness [3][4][6] Group 2 - Neuralink, led by Elon Musk, announced that its BCI devices will enter mass production in 2026, along with a breakthrough in automated surgical technology for implanting devices [3] - A new industry standard for BCI medical devices in China, effective January 1, 2026, aims to provide regulatory clarity and facilitate clinical trials and product approvals [4] - A successful human trial in China demonstrated the ability to restore movement in paralyzed patients using implanted electrodes, showcasing rapid advancements in BCI technology [6] Group 3 - Investment interest in the BCI sector is heightened, with major international banks like Goldman Sachs, BNP Paribas, and Morgan Stanley focusing on companies like Innovation Medical, which has a strategic advantage due to its hospital resources [8] - The global BCI market is projected to reach $12.4 billion by 2034, with a compound annual growth rate of 17% from 2025 to 2034, indicating strong long-term growth potential [9] - The potential applications of BCI technology are expanding beyond medical uses, with possibilities in consumer electronics and smart home integration, suggesting a broader market impact [11] Group 4 - Despite the excitement, challenges remain in ensuring the long-term viability of implanted electrodes and improving the accuracy of non-invasive BCI systems [12] - Following the stock price surge, regulatory bodies have issued inquiries to several companies in the BCI sector to ensure transparency regarding their business operations and R&D progress [12] - Innovation Medical's stock has seen significant increases, but analysts caution that its current valuation is high, and investors should monitor the actual progress of its BCI projects and their impact on profitability [14]

创新医疗、倍益康、三博脑科、南京熊猫、美好医疗涨停，熵基科技涨超15%，麦澜德、爱朋医疗涨超 10%。 (本文来自第一财经) ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The brain-computer interface (BCI) technology is undergoing a period of accelerated transformation, with various technical paths available, including invasive, semi-invasive, and non-invasive methods, each with its own advantages in signal quality, safety, and operational difficulty [5][19] - The Chinese brain-computer interface market is projected to grow significantly, with the market size reaching approximately 1.73 billion yuan in 2023, accounting for 12.5% of the global market [6] - The industry is supported by a three-pronged policy approach focusing on planning, payment, and standards, which is expected to facilitate rapid development [6][33] Summary by Sections 1. Brain-Computer Interface Overview - BCI is a multidisciplinary technology that integrates neuroscience, computer science, and engineering to enable communication between the brain and external devices [17] - The technology operates through a closed-loop system involving signal input, processing, device control, and feedback [17] 2. Policy Support for BCI Development - The Chinese government has issued several policies to support the BCI industry, including the "Implementation Opinions on Promoting the Innovation and Development of the Brain-Computer Interface Industry" which outlines goals for 2027 and 2030 [6][43] - The policies aim to establish a robust industrial ecosystem, enhance innovation capabilities, and promote clinical applications of BCI technologies [43][44] 3. Technological Advancements and Applications - Core technological breakthroughs are occurring in the upstream segment of the BCI industry, particularly in hardware such as electrodes and chips [7] - The medical application of BCI is predominant, with 56% of the market share in 2023, focusing on various therapeutic areas including cognitive disorders and movement disabilities [7][9] - Companies like Lepu Medical and Aipeng Medical are actively involved in developing deep brain stimulation (DBS) technologies, with some preparing for IPOs [7][8] 4. Investment Recommendations - The report suggests focusing on both invasive and non-invasive BCI products, with specific companies identified as beneficiaries based on their clinical trial progress and commercialization potential [8] - Notable companies include Aipeng Medical and Lepu Medical for invasive products, and Xiangyu Medical and Innovation Medical for non-invasive products [8]

热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 继昨日A股实现新年"开门红"行情，1月6日沪指再次刷新十年高点，盘中涨幅接近1%。现货指数出 现"破顶"，沪深300、上证50、中证500、中证1000均刷新2025年高点，市场表现价涨量增。行业板块出 现普涨行情，保险、券商"大象起舞"拉动上证50指数站稳3100点，内外盘科技板块同步上涨，脑机接 口、半导体等大幅领涨，叠加贵金属、有色受地缘事件影响延续涨势，中证500和中证1000涨幅居前。 资金来看，昨日两市全天成交2.55万亿，大幅放量5011亿，另外近期人民币不断升值，后续或持续吸引 外资流入。接下来进入年报披露期，持续关注高成长的大科技成长板块，股指短期或偏强震荡。 行业政策持续加码，昨日政策端印发《关于实施绿色消费推进行动的通知》，加快消费模式绿色转型， 在大宗商品消费方面，提及做强汽车产业链，支持发展房车露营、汽车影院、自驾游等新型消费。宏观 方面，短期关注货币政策和财政政策是否进一步宽松。整体来看，春季躁动行情仍需要一定的条件，对 小盘指数而言，需要政策边际放宽流动性；对大盘而言，需要通胀预期的持续改善。 热点栏目 自选股 数 ...

机构观点方面，华西证券指出，2026年是多个正面因素叠加的"大年"，牛市基础仍扎实，且春季躁动已 提前演绎：一是宏观政策周期来看，2026年作为"十五五"开局之年，多部门正密集出台配套产业政策和 投资规划，同时财政货币政策的协同发力，为市场营造了友好的流动性环境；二是资金层面，12月以股 票型ETF为代表的机构资金出现抢跑，后续保险资金"开门红"叠加汇率升值驱动下外资回流，增量资金 入市有望强化春季行情趋势；三是基本面预期与产业周期来看，随着PPI降幅收窄，预计2026年企业盈 利进入温和复苏通道，对盈利拐点的博弈将成为行情的重要支撑。 长江证券资深投资顾问刘浪表示，昨天脑机接口概念股全线爆发。据媒体报道，复旦大学附属华山医院 脑机接口植入技术再获突破。国内首款、国际第二款内置电池的全植入、全无线、全功能"三全"脑机接 口产品，成功完成首例临床试验。28岁高位截瘫8年的患者通过植入脑机接口系统，第一次用意念控制 轮椅、浏览网页……这项技术突破标志着中国在脑机接口领域已跻身全球顶尖序列。另外，近期埃隆· 马斯克表态，旗下Neuralink将在2026年启动脑机接口设备大规模生产。开源证券认为，脑机接口行业正 处 ...